Companies:

Articles:

Tryptamine Therapeutics Limited (ASX: TYP)

Company news

Cover Image for Tryptamine Therapeutics advances psychedelic drug candidate TRP-8803 after positive safety review

Tryptamine Therapeutics advances psychedelic drug candidate TRP-8803 after positive safety review

October 18, 2024

Cover Image for Tryptamine Therapeutics achieves milestone of world’s first IV-infused psilocin dosing

Tryptamine Therapeutics achieves milestone of world’s first IV-infused psilocin dosing

July 1, 2024